Upregulation of NFE2L1 reduces ROS levels and α-synuclein aggregation caused by GBA1 knockdown
Biochemical and Biophysical Research Communications · 2024
DOI: 10.1016/j.bbrc.2024.150640 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Yajun Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Metabolism and Molecular Medicine, Ministry of Education, Department of Biochemistry and Molecular Biology, School of Basic Medical…. Hauptthemen laut MEDLINE: alpha-Synuclein, Reactive Oxygen Species, Glucosylceramidase, Up-Regulation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Innovative Research Group Project of the National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Biallelic mutations in the GBA1 gene result in Gaucher disease (GD), and both patients with GD and carriers of a single GBA1 mutation have an increased susceptibility to Parkinson's disease (PD), but the underlying mechanisms of this association are not yet clear. In previous studies, we established Gba1 F213I point mutation mice and found that homozygous Gba1 F213I mutant mice died shortly after birth, while heterozygous mice could survive normally. In this study, we investigated the transcriptomic changes in the brain tissue of Gba1 F213I heterozygous mice, identifying 138 differentially expressed genes. Among them, Nfe2l1 was the most significantly downregulated gene. Inhibition or knockdown of GBA1 in BE(2)-M17 cells resulted in decreased expression levels of NFE2L1. Knockdown of GBA1 or NFE2L1 could lead to an elevation in intracellular aggregation of α-synuclein (α-syn) and reactive oxygen species (ROS) levels, while upregulation of NFE2L1 effectively mitigated those cellular manifestations induced by GBA1 knockdown. In summary, our in vitro results showed that upregulation of NFE2L1 may provide a therapeutic benefit for cellular phenotypes resulting from GBA1 knockdown, providing new insights for future research on GD and GBA1-associated PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Metabolism and Molecular Medicine, Ministry of Education, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, 20003…
Förderung
- National Natural Science Foundation of China
- Innovative Research Group Project of the National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Li, Y., Wen, S., Xiang, W., Shen, F., Jiang, N., Zhang, J., & Ma, D. (2024). Upregulation of NFE2L1 reduces ROS levels and α-synuclein aggregation caused by GBA1 knockdown. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150640
Vancouver
Li Y, Wen S, Xiang W, Shen F, Jiang N, Zhang J, et al. Upregulation of NFE2L1 reduces ROS levels and α-synuclein aggregation caused by GBA1 knockdown. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150640
BibTeX
@article{Li2024,
author = {Li, Yajun and Wen, Shuxia and Xiang, Wanqing and Shen, Fei and Jiang, Nan and Zhang, Jin and Ma, Duan},
title = {Upregulation of NFE2L1 reduces ROS levels and α-synuclein aggregation caused by GBA1 knockdown},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
doi = {10.1016/j.bbrc.2024.150640}
}
EUVIMED